Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial

IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the standard dose, reducing the risk of symptomatic intracerebral hemorrhage. There is uncertainty, however, over how this effect translates into an overall clinical benefit for patients with acute ischemic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA Neurol
Prif Awduron: Wang, Xia, Robinson, Thompson G., Lee, Tsong-Hai, Li, Qiang, Arima, Hisatomi, Bath, Philip M., Billot, Laurent, Broderick, Joseph, Demchuk, Andrew M., Donnan, Geoffrey, Kim, Jong S., Lavados, Pablo, Lindley, Richard I., Martins, Sheila O., Olavarria, Veronica V., Pandian, Jeyaraj D., Parsons, Mark W., Pontes-Neto, Octavio M., Ricci, Stefano, Sharma, Vijay K., Thang, Nguyen H., Wang, Ji-Guang, Woodward, Mark, Anderson, Craig S., Chalmers, John
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2017
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822216/
https://ncbi.nlm.nih.gov/pubmed/28973174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2286
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg